Strategy | Financing Highlight Private Placement / Financing TransactionsEikon Therapeutics: The company raised $140.8 million of Series C venture funding from undisclosed investors on June 1, 2023. The company is a developer of a drug discovery platform designed to...
Strategy | Financing Highlight Private Placement / Financing Transactions ReNAgade Therapeutics: The company raised $300 million of Series A venture funding in a deal led by MPM Capital and F2 Ventures on May 23, 2023. BioImpact Capital and Alexandria Venture...
Strategy | Financing Highlight Private Placement / Financing Transactions Ensoma: The company raised $135 million of Series B venture funding in a deal led by 5AM Ventures and Arix Bioscience on May 16, 2023, putting the company’s pre-money valuation at $130...
Strategy | Financing Highlight Private Placement / Financing Transactions Cullgen: The company raised $40 million through a combination of debt and Series C venture funding in a deal led by Wuxi AstraZeneca CICC Venture Capital Partnership on May 8, 2023, putting the...
Strategy | Financing Highlight Private Placement / Financing Transactions Convergent Therapeutics: The company raised $90 million of Series A1 venture funding in a deal led by OrbiMed and RA Capital Management on May 3, 2023, putting the company’s pre-money...
Strategy | Financing Highlight Private Placement / Financing Transactions Orbital Therapeutics: The company raised $270 million of Series A venture funding in a deal led by ARCH Venture Partners on April 26, 2023. Alexandria Venture Investments, Heritage Medical...
